Adding Lurbinectedin to First-Line Atezolizumab Maintenance Treatment Prolongs Survival Over Atezolizumab Alone in Patients with ES-SCLC By Ogkologos - July 14, 2025 312 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the IMforte study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer ESMO Calls for Robust EU Taxation of Tobacco Products, Aiming to Prevent Cancers Attributable to Tobacco Use EMA Recommends Granting a Marketing Authorisation for Biosimilar Pegfilgrastim MOST POPULAR New Mom Was Told a Lump in Her Breast Was “Built-Up... April 5, 2019 How Are Eligibility Criteria for Clinical Trials Changing to Help People... June 10, 2021 No Benefit for Post-operative Radiotherapy in Non-small-cell Lung Cancer [ESMO2020 Press... September 20, 2020 Online Dating During COVID-19 and Cancer: What to Know February 11, 2021 Load more HOT NEWS How Joining a Clinical Trial Helped Me Find Hope While Living... Impact of Multigene Germline Genetic Testing on Selection of Germline-Directed Therapy... This Program Provides Free Mammograms And Breast Cancer Treatment Services To... Long-Term Survival in a Significant Proportion of Patients with a 1p/19q...
